ENTITY

Genkyotex SA (GKTX FP)

5
Analysis
Health CareFrance
Genkyotex is a biopharmaceutical company that conducts NOX therapies. The company is listed on the Euronext Paris and Euronext Brussels markets. Genkyotex's therapeutic approach is based on a selective inhibition of NOX enzymes that amplify multiple disease processes such as fibrosis, inflammation, pain processing, cancer development, and neurodegeneration.
more
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
x